A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive

Stopped Stopped for futility. Phase 3 studies not likely to meet primary endpoints.

Conditions

• Healthy

Interventions

• DRUG: Lanabecestat
• DRUG: Oral Contraceptive

Sponsor

Eli Lilly and Company

Collaborators

• [object Object]